Mezim forte tab. p / o No. 20
Package quantity, pcs:
twenty
80
Category
Enzymes
Scope of the drug
Gastrointestinal tract
Release form
Tablet
Manufacturer country
Germany
Package quantity, pcs
twenty
Film-coated tablets.
The drug compensates for the insufficiency of the exocrine function of the pancreas.
The enzymes lipase, amylase and protease, which are part of pancreatin, facilitate the digestion of fats, carbohydrates and proteins, which contributes to their more complete absorption in the small intestine.
Name ENG
MEZYM FORTE
Clinical and pharmacological group
Enzyme preparation
ATX code
A09AA02 (Multienzymes (lipase, protease etc.))
Dosage
Pancreatin with minimal enzymatic activity: lipases 3500 U Ph.Eur
amylase 4200 U Ph.Eur
proteases 250 U Ph.Eur
Structure
1 tablet contains: Active substances: pancreatin with minimal enzymatic activity: lipase 3500 U Ph.Eur
amylase 4200 U Ph.Eur
proteases 250 U Ph.Eur.
Excipients: microcrystalline cellulose, sodium carboxymethyl starch (type A), colloidal silicon dioxide, magnesium stearate.
Shell composition: talc, hypromellose, azorubin varnish (E122), simethicone emulsion 30% (dry weight), polyacrylate dispersion 30% (dry weight), titanium dioxide (E171), macrogol 6000.
Indications
Substitution therapy for exocrine insufficiency of pancreatic functions (including chronic pancreatitis, cystic fibrosis)
chronic inflammatory-dystrophic diseases of the stomach, intestines, liver, gallbladder
conditions after resection or irradiation of the digestive tract, accompanied by impaired digestion of food, flatulence, diarrhea (as part of combination therapy)
functional gastrointestinal tract disorder (with intestinal infectious diseases, irritable bowel syndrome, etc.)
to improve the digestion of food in patients with normal gastrointestinal tract function in case of nutritional errors
preparation for X-ray and ultrasound examinations of the abdominal organs.
Contraindications
Acute pancreatitis
exacerbation of chronic pancreatitis
hypersensitivity to pancreatin or other components of the drug
hereditary galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome
children under 3 years of age (indivisible dosage form).
INN / Active ingredient
Pancreatin
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
Specifications
Category
Enzymes
Scope of the drug
Gastrointestinal tract
Release form
Tablet
Manufacturer country
Germany
Package quantity, pcs
twenty
Scope of application
Gastroenterology
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Berlin-Chemie
The amount of the dosage form in the primary package
20 pcs.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Digestive Enzyme Remedy
Anatomical and therapeutic characteristics
A09AA02 Polyenzyme preparations (lipase + protease, etc.)
Dosage form
Film-coated tablets
Expiration date in days
1095
Package weight, g
15
Mode of application
:
The dose is determined individually, depending on the degree of indigestion.
< br> Adults: 1-2 tab.
before meals, without chewing and drinking water.
If necessary, additionally during meals, take another 1-4 tab.
< br> In children: the drug is used as directed by a doctor.
< br> < br> The duration of treatment can vary from several days (if the digestive process is disturbed due to dietary errors) to several months or years (if constant substitution therapy is necessary).
Dosage (volume) of the substance in the preparation
:
lipase 3500 U Ph.Eur, amylase 4200 U Ph.Eur, proteases 250 U Ph.Eur